These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 21263240)
1. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast. Tramm T; Kim JY; Tavassoli FA Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240 [TBL] [Abstract][Full Text] [Related]
2. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast. Elayat G; Selim AG; Wells CA Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450 [TBL] [Abstract][Full Text] [Related]
3. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast. Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673 [No Abstract] [Full Text] [Related]
4. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions. Shim HS; Jung WH; Kim H; Park K; Cho NH APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011 [TBL] [Abstract][Full Text] [Related]
5. A case of sebaceoma with extensive apocrine differentiation. Tanahashi J; Kashima K; Daa T; Kondoh Y; Yada N; Kuratomi E; Yokoyama S Am J Dermatopathol; 2008 Aug; 30(4):408-11. PubMed ID: 18645320 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Gatalica Z Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Moriya T; Sakamoto K; Sasano H; Kawanaka M; Sonoo H; Manabe T; Ito J Mod Pathol; 2000 Jan; 13(1):13-8. PubMed ID: 10658905 [TBL] [Abstract][Full Text] [Related]
8. [Apocrine carcinoma of the breast--a morphologic comparison of the apocrine sweat glands and the apocrine metaplastic epithelia in mastopathy]. Tsubura A; Uemura Y; Inui T; Izumi H; Morii S Gan No Rinsho; 1988 Jun; 34(7):901-7. PubMed ID: 3398262 [TBL] [Abstract][Full Text] [Related]
9. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. Miyamoto T; Hagari Y; Inoue S; Watanabe T; Yoshino T J Clin Pathol; 2005 Jul; 58(7):757-61. PubMed ID: 15976347 [TBL] [Abstract][Full Text] [Related]
10. Apocrine adenoma of the breast. Cashell AW W V Med J; 2008; 104(2):16-9. PubMed ID: 18491794 [TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions. Wood A; Houghton SL; Biswas A Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681 [TBL] [Abstract][Full Text] [Related]
12. Apocrine adenoma of the breast coexistent with invasive carcinoma. Bezić J; Forempoher G; Poljicanin A; Gunjaca G Pathol Res Pract; 2007; 203(11):809-12. PubMed ID: 17936522 [TBL] [Abstract][Full Text] [Related]
13. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast. Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644 [TBL] [Abstract][Full Text] [Related]
14. Apocrine mixed tumor of the skin ("mixed tumor of the folliculosebaceous-apocrine complex"). Spectrum of differentiations and metaplastic changes in the epithelial, myoepithelial, and stromal components based on a histopathologic study of 244 cases. Kazakov DV; Belousova IE; Bisceglia M; Calonje E; Emberger M; Grayson W; Hantschke M; Kempf W; Kutzner H; Michal M; Spagnolo DV; Virolainen S; Zelger B J Am Acad Dermatol; 2007 Sep; 57(3):467-83. PubMed ID: 17707152 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic alterations in myoepithelial cells of the breast in normal and pathologic conditions. Pusztaszeri M Am J Surg Pathol; 2010 Dec; 34(12):1886; author reply 1886-7. PubMed ID: 21107098 [No Abstract] [Full Text] [Related]
16. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature. Parks A; Branch KD; Metcalf J; Underwood P; Young J Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361 [TBL] [Abstract][Full Text] [Related]
17. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Gottlieb C; Raju U; Greenwald KA Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493 [TBL] [Abstract][Full Text] [Related]
18. Intraductal carcinoma of mammary-type apocrine epithelium arising within a papillary hydradenoma of the vulva. Report of a case and review of the literature. Pelosi G; Martignoni G; Bonetti F Arch Pathol Lab Med; 1991 Dec; 115(12):1249-54. PubMed ID: 1662944 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Hilson JB; Schnitt SJ; Collins LC Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570 [TBL] [Abstract][Full Text] [Related]
20. Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy. Cserni G APMIS; 2012 Mar; 120(3):249-52. PubMed ID: 22339683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]